HomepageBlogAGC Plans to Invest Over 200B Yen in CDMO Operations for Gene & Cell Therapy, More Blog AGC Plans to Invest Over 200B Yen in CDMO Operations for Gene & Cell Therapy, More admin Posted on August 14, 2023 AGC Inc. (TYO:5201) is looking to invest more than 200 billion yen ($1.7 billion) into CDMO operations by 2025. Plans…… Please subscribe to read the full story. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Post navigation Next PostChemical Innovation: Unveiling the Dynamics of Japan’s Thriving Chemical Industry You Might Also Like Blog JSR to Boost Production Capacity for Advanced Semiconductor Photoresists admin August 14, 2023 Blog Interview: Asahi Kasei President Hideki Kobori Talks Shifting Global Business Landscape, Company Structure and Sustainability admin August 14, 2023 Blog Sharp Rise in Demand for Wind Power Applications Tightens Carbon Fiber Market admin August 14, 2023 Blog AEPW Makes Fivefold Increase to Plastic Recycling Investment Targets admin August 14, 2023
Blog Interview: Asahi Kasei President Hideki Kobori Talks Shifting Global Business Landscape, Company Structure and Sustainability admin August 14, 2023
Blog Sharp Rise in Demand for Wind Power Applications Tightens Carbon Fiber Market admin August 14, 2023
From Chemistry to Energy: Unveiling the Integral Role of Chemical Reactions in Power Generation September 30, 2023